NCT05214820View on ClinicalTrials.gov

68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Upper Digestive Tract Cancer
Interventions
BIOLOGICAL

Radiopharmaceutical 68Ga-PSMA

Injection of 68Ga-PSMA followed by 3 PET/CT acquisitions

Trial Locations (1)

J1H 5N4

RECRUITING

CIUSSS de l'Estrie- CHUS Hospital, Sherbrooke

All Listed Sponsors
lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER